ACTA
PHARMACEUTICA
Acta Pharm. Vol. 69
No. 1 pp. 1-130
Zagreb, March 2019
TABLE OF
CONTENTS
ORIGINAL RESEARCH
PAPERS
I.
I. Hamdan, V. N. Kasabri, Y. M. Al-Hiari, D. El-Sabawi and H. Zalloum
Pancreatic lipase inhibitory activity of selected
pharmaceutical agents
M. Preskar, T. Vrbanec, F. Vrečer, P. Šket, J. Plavec and M. Gašperlin
Solubilization of ibuprofen for freeze dried parenteral dosage forms
R. Rutckeviski, F. H. Xavier, A. Rochelli Do Vale
Morais, L. Amaral-Machado, E. Do Nascimento Alencar, J. Genre, A. Antunes De
Souza Araujo and E. S. Tabosa Do Egito
Therapeutic bullfrog oil-based nanoemulsion for
oral application: Development, characterization and stability
L. S. Mbatha, F. Chepkoech Maiyo and M. Singh
Dendrimer functionalized folate-targeted gold
nanoparticles for luciferase gene silencing in
vitro: A proof of principle study
A. Testen, M. Plevnik, B. Štefane and I. Kralj
Cigić
Identification of new process-related impurity in the key intermediate in
the synthesis of TCV-116
A. Sabran, E. Kumolosasi and
I. Jantan
Effects of annexin A1 on
apoptosis and cell cycle arrest in human leukemic cell lines
S. Sattar, M. Ahmad, H. Saeed, Z. Saleem, Z.
Danish and M. Akhlaq
Comparison of clinico-pathological characteristics and survival of
recurrent ovarian cancer patients on seven different chemo-protocols
E.
J. Barbosa and H. Gomes Ferraz
Gellan gum and
polyvinylpyrrolidone (PVP) as binder agents in extrusion/spheronization
pelltets formulations
SHORT
COMMUNICATIONS
X.
Wang, S. Huang, X. Xin, Y. Ren, G. Weng and P. Wang
The
antitumor activity of umbelliferone in human renal cell carcinoma via
regulation of the p110γ catalytic subunit of PI3Kγ
M. Ambrož, M. Šmatová, M.
Šadibolová, E. Pospíšilová, P. Hadravská, M. Kašparová, V. Hanušová Skarková,
V. Králová and L. Skálová
Sesquiterpenes α-humulene and
β-caryophyllene oxide enhance the efficacy of 5-fluorouracil and
oxaliplatin in colon cancer cells